Pharma news
Americas
Law firm McMillan has hired Stuart Kruger as a partner in the firm’s pharmaceuticals and biotechnology practice in Montreal. 26 May 2016
Americas
Each ‘patent dance’ dispute between biologics and biosimilars companies will present its own nuances in the process of solving the mystery, argue Lisa Pensabene and Daniel O'Boyle of O’Melveny & Myers. 26 May 2016
Americas
Egalet Corporation announced that it has reached an agreement with Purdue Pharma regarding the alleged patent infringements by Egalet and product licensor Acura Pharmaceuticals through Oxaydo tablets. 25 May 2016
Americas
Monsanto has rejected Bayer’s $62 billion buyout offer that would have created the world’s largest agricultural supplier, calling the bid “incomplete and financially inadequate”, but said it was open to negotiate further. 25 May 2016
Pharma
Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion. 24 May 2016
Americas
Colombia’s health ministry has warned Novartis that it might override a patent that the company owns covering cancer drug Gleevec. 20 May 2016
Americas
Law firm Lathrop & Gage has hired Alan Steele as a counsel in its intellectual property practice group in Boston. 19 May 2016
Americas
US-based law firm Burns & Levinson has hired Shawn Foley as of counsel in the firm’s intellectual property practice in Boston. 19 May 2016
Americas
Pfizer has announced that it will be buying Anacor Pharmaceuticals for $5.2 billion, which will lead to it adding an experimental treatment for eczema, called Crisaborole, to its portfolio. 18 May 2016
Americas
The US Patent and Trademark Office’s Patent Trial and Appeal Board will review one of AbbVie’s patents covering its arthritis treatment drug Humira (adalimumab), following a challenge by drug maker Coherus Bioscience. 18 May 2016